drugset

drugset / Trial / NCT07439042

Buspirone for Anxiety in Autistic Youth

NCT07439042 ↗

Phase 4 Recruiting 20 enrolled Massachusetts General Hospital

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to do a preliminary trial to determine if buspirone is effective, safe, and tolerable in autistic youth with anxiety.

Timeline

Start: 2026-09
Primary completion: 2029-02
Completion: 2029-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Buspirone	Small molecule	—	—

Indications